Manus Bio is awarded a Phase II SBIR Grant from the National Science Foundation to continue development of a low-cost production platform for a potent natural acaricide
CAMBRIDGE, Mass., September 1, 2017 - Manus Bio announced today that it has been awarded the second phase of the National Science Foundation grant under the America's Seed Fund program. This Phase II award ($600,000) acknowledges the significant progress attained in the first phase and will continue to support the development of an advanced fermentation process for the economical and sustainable production of a highly potent natural acaricide. The full project abstract can be found at https://www.nsf.gov/awardsearch/showAward?AWD_ID=1738463.
About Manus Bio
Manus Bio is a global leader in the use of advanced fermentation technology for manufacturing complex, bioactive natural products as flavors, fragrances, food ingredients, biopesticides, and pharmaceuticals. The core team and technology are from MIT, and the company is headquartered in Cambridge, MA, USA. For more information, visit www.manusbio.com.
About America’s Seed Fund
America’s Seed Fund powered by the National Science Foundation (NSF) awards nearly $190 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $1.5 million in non-dilutive funds to support research and development (R&D),helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $7.5 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.